Abstract:Redirecting CD8 T cell immunity with self/tumor-specific affinity-matured T cell receptors (TCRs) is a promising approach for clinical adoptive T cell therapy, with the aim to improve treatment efficacy. Despite numerous functional-based studies, little is known about the characteristics of TCR signaling (i.e., intensity, duration, and amplification) and the regulatory mechanisms underlying optimal therapeutic T cell responses. Using a panel of human SUP-T1 and primary CD8 T cells engineered with incremental affinity TCRs against the cancer-testis antigen NY-ESO-1, we found that upon activation, T cells with optimal-affinity TCRs generated intense and sustained proximal (CD3ζ, LCK) signals associated with distal (ERK1/2) amplification-gain and increased function. In contrast, in T cells with very high affinity TCRs, signal initiation was rapid and strong yet only transient, resulting in poor MAPK activation and low proliferation potential even at high antigen stimulation dose. Under resting conditions, the levels of surface TCR/CD3ε, CD8β, and CD28 expression and of CD3ζ phosphorylation were significantly reduced in those hyporesponsive cells, suggesting the presence of TCR affinity-related activation thresholds. We also show that SHP phosphatases were involved along the TCR affinity gradient, but displayed spatially distinct regulatory roles. While PTPN6/SHP-1 phosphatase activity controlled TCR signaling initiation and subsequent amplification by counteracting CD3ζ and ERK1/2 phosphorylation, PTPN11/SHP-2 augmented MAPK activation without affecting proximal TCR signaling. Together, our findings indicate that optimal TCR signaling can be finely tuned by TCR affinity-dependent SHP-1 and SHP-2 activity, and this may readily be determined at the TCR/CD3 complex level. We propose that these TCR affinity-associated regulations represent potential protective mechanisms preventing high affinity TCR-mediated autoimmune diseases.

SLP-76 interaction with PLC-γ1 fine-tunes TCR signal strength for appropriate thymocyte selection, T cell homeostasis, and Ag-specific T cell response

Conditional Deletion Of Shp2 Tyrosine Phosphatase In Thymocytes Suppresses Both Pre-Tcr And Tcr Signals

Increased targeting of donor switch region and IgE in Sgamma1-deficient B cells.

Molecular Cloning of SLP-76, a 76-Kda Tyrosine Phosphoprotein Associated with Grb2 in T Cells

Increased Targeting of Donor Switch Region and IgE in Sγ1-Deficient B Cells

Thymic Selection Can Compensate for Mutations Affecting T Cell Activation and Generate a Normal T Cell Repertoire in Mutant Mice

Interaction of SLP adaptors with the SH2 domain of Tec family kinases.

Cutting Edge: TCR- Selection Is Required at the CD4<SUP>+</SUP>CD8<SUP>+</SUP> Stage of Human T Cell Development

Scaffold Protein Jlp Mediates Tcr-Initiated Cd4(+)T Cell Activation and Cd154 Expression

TCR ligand discrimination is enforced by competing ERK positive and SHP-1 negative feedback pathways

SLAM receptors foster iNKT cell development by reducing TCR signal strength after positive selection

SLAM/SAP signaling regulates discrete γδ T cell developmental checkpoints and shapes the innate-like γδ TCR repertoire

Autoregulated splicing of TRA2 β programs T cell fate in response to antigen-receptor stimulation

Conformational switches that control the TEC kinase - PLCγ signaling axis

PP6 Controls T Cell Development and Homeostasis by Negatively Regulating Distal TCR Signaling

Fine-Tuning of Optimal TCR Signaling in Tumor-Redirected CD8 T Cells by Distinct TCR Affinity-Mediated Mechanisms

Glycogen Synthase Kinase-3 Modulates Cbl-b and Constrains T Cell Activation.

Cbl-b mitigates the responsiveness of naive CD8 + T cells that experience extensive tonic T cell receptor signaling

A single-amino acid substitution in the adaptor LAT accelerates TCR proofreading kinetics and alters T-cell selection, maintenance and function

LKB1 isoform expression modulates T cell plasticity downstream of PKCθ and IL-6

Regulatory T Cells Require TCR Signaling for Their Suppressive Function.